(Total Views: 543)
Posted On: 10/16/2025 3:14:44 PM
Post# of 158044
Re: Buddyboy20 #157988
Quote:
Leronlimab lowers CTCs very early during treatment, rendering the blood test implausible. That means the patient's primary tumor would be biopsied every two weeks. That could be very tough to go through.
Lower CTCs are no problem because what they are testing for is percentage of CTCs with PD-L1 expression.
(12)
(0)
